Cytokeratin 18 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Cytokeratin 18 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCytokeratin 18
Clone[IHC018]
Host SpeciesMouse
Reactive Specieshuman
Isotypen/a
Formatunconjugated
Size0.1 mL (Concentrate), 7 mL (Prediluted), 1 mL (Concentrate)
Concentrationn/a
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionIntended Use: The Cytokeratin 18 [IHC018] antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. Description: Cytokeratin 18 (CK18) is present in simple, glandular, and transitional epithelial cells, but is absent in stratified epithelial cells. CK18 usually multimerizes with Cytokeratin 8, and Anti-Cytokeratin 18 is useful for detecting adenocarcinomas of simple and glandular epithelium origin, as well as poorly differentiated squamous carcinoma cells.
Immunogenn/a
Other Names[cytokeratin 18; Keratin, type I cytoskeletal 18; keratin, type I cytoskeletal 18; keratin 18; Cell proliferation-inducing gene 46 protein; Cytokeratin-18; CK-18; Keratin-18; K18], [KRT18; KRT18; K18; CK-18; CYK18; CYK18; CK-18; K18]
Gene, Accession #Gene ID: 3875, NCBI: CAA31375.1, UniProt: P05783
Catalog #MBS344011
Price$160, $195, $245
Order / More InfoCytokeratin 18 Antibody from MYBIOSOURCE INC.
Product Specific References1. Moll R. Subcell Biochem. 1998; 31:205-62.2. Ku NO, et al. J Clin Invest. 1997; 99:19-23.3. Woelfle U, et al. Clin Cancer Res. 2004; 10:2670
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.